Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

What’s new in smart pens and caps for capturing injection doses? Plus, two cool new health apps with built-in artificial intelligence
A new challenge from Amazon and Merck calls for innovative solutions that use Alexa voice technology to help improve diabetes management
Learn from the experts about how best to support teens with diabetes and engage in difficult health and wellbeing conversations
One Drop Premium and Bluetooth-enabled Chrome meter available in US and EU, as well as 24/7 in-app support
Cash-pay strips with good accuracy and co-pay programs to save money
The new blood glucose meter features less expensive strips, uploads readings to smartphones, and integrates with mySugr
How diabetes educators see people with diabetes differently – research from the American Association of Diabetes Educators conference
New Dexcom and Fitbit collaboration to put CGM data on the wrist, a convenience win and the third smartwatch platform for Fitbit. What else might they develop?
Novo Nordisk’s once-weekly injectable GLP-1 for type 2 diabetes recommended for approval, given strong A1c reduction and weight loss
A decision on Novo Nordisk’s faster-acting mealtime insulin is expected in late 2017; also launched in Canada, Germany, and the UK, and coming soon to more European...
With Roche’s support, mySugr will expand to more countries and will even begin offering a new package with unlimited test strips and diabetes coaching through German...
Dr. Shreela Sharma’s advice for eating well, moving more, and making goals stick in the New Year
New Livongo Family Care Plan available without a prescription or insurance
Novo Nordisk’s newest insulin receives EMA approval; expected to launch in the first half of 2017
Why a good night of sleep transforms Adam Brown's diabetes the next day
A recent trial comparing once-weekly GLP-1 agonists semaglutide and Trulicity found improved A1c and double the weight loss with semaglutide
Leading scientists discuss areas of growth ranging from behavior to artificial intelligence at The diaTribe Foundation’s “Solvable Problems” event in Lisbon
Easy-to-use Bydureon pen cuts down on the hassle of once-weekly injections by offering convenient mixing, a hidden needle, and more​
The hardest chapter to write: my story
Continuously delivers GLP-1 agonist for 3-6 months; FDA decision is expected by the end of 2017